These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21219435)

  • 1. Effects of meals with different glycaemic index on postprandial blood glucose response in patients with Type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Parillo M; Annuzzi G; Rivellese AA; Bozzetto L; Alessandrini R; Riccardi G; Capaldo B
    Diabet Med; 2011 Feb; 28(2):227-9. PubMed ID: 21219435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Children and adolescents on intensive insulin therapy maintain postprandial glycaemic control without precise carbohydrate counting.
    Smart CE; Ross K; Edge JA; Collins CE; Colyvas K; King BR
    Diabet Med; 2009 Mar; 26(3):279-85. PubMed ID: 19317823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
    Shashaj B; Busetto E; Sulli N
    Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
    Sahin SB; Cetinkalp S; Ozgen AG; Saygili F; Yilmaz C
    Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In children using intensive insulin therapy, a 20-g variation in carbohydrate amount significantly impacts on postprandial glycaemia.
    Smart CE; King BR; McElduff P; Collins CE
    Diabet Med; 2012 Jul; 29(7):e21-4. PubMed ID: 22268422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of popular takeaway foods on blood glucose levels in type 1 diabetes mellitus patients on intensive insulin therapy.
    MacDonald K; Lowe JM; Barker D; Mensch M; Attia J
    Int J Clin Pract; 2009 Feb; 63(2):189-94. PubMed ID: 19196356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Siebenhofer A; Jeitler K; Berghold A; Horvath K; Pieber TR
    Diabet Med; 2009 Mar; 26(3):311-2; author reply 312-3. PubMed ID: 19317829
    [No Abstract]   [Full Text] [Related]  

  • 8. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of insulin with oral nutrients on whole-body protein metabolism in growing pubertal children with type 1 diabetes.
    Braziuniene I; Garlick J; Mileva I; Desikan V; Wilson TA; McNurlan M
    Pediatr Res; 2009 Jan; 65(1):109-12. PubMed ID: 18703999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Many patients with Type 1 diabetes estimate their prandial insulin need inappropriately.
    Ahola AJ; Mäkimattila S; Saraheimo M; Mikkilä V; Forsblom C; Freese R; Groop PH;
    J Diabetes; 2010 Sep; 2(3):194-202. PubMed ID: 20923484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
    Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
    Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes.
    Todd JF; Edwards CM; Ghatei MA; Mather HM; Bloom SR
    Clin Sci (Lond); 1998 Sep; 95(3):325-9. PubMed ID: 9730852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of breakfast meal composition on second meal metabolic responses in adults with Type 2 diabetes mellitus.
    Clark CA; Gardiner J; McBurney MI; Anderson S; Weatherspoon LJ; Henry DN; Hord NG
    Eur J Clin Nutr; 2006 Sep; 60(9):1122-9. PubMed ID: 16670695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.
    Liebl A; Hoogma R; Renard E; Geelhoed-Duijvestijn PH; Klein E; Diglas J; Kessler L; Melki V; Diem P; Brun JM; Schaepelynck-Bélicar P; Frei T;
    Diabetes Obes Metab; 2009 Nov; 11(11):1001-8. PubMed ID: 19740082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes.
    Parkner T; Møller MK; Chen JW; Laursen T; Jørgensen C; Smedegaard JS; Lauritzen T; Christiansen JS
    Diabetes Obes Metab; 2008 Jul; 10(7):556-63. PubMed ID: 17593233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal diabetes and insulin pump therapy.
    Beardsall K; Pesterfield CL; Acerini CL
    Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F223-4. PubMed ID: 21115555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of the treatment with continuous subcutaneous insulin infusion (CSII) in the improvement of the quality of life of patients with type 1 diabetes mellitus].
    Casas-Oñate ML; Montoya-Martínez D
    Enferm Clin; 2010; 20(4):216-21. PubMed ID: 20561806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised controlled trial of insulin lispro given before or after meals in pregnant women with type 1 diabetes--the effect on glycaemic excursion.
    Carr KJ; Idama TO; Masson EA; Ellis K; Lindow SW
    J Obstet Gynaecol; 2004 Jun; 24(4):382-6. PubMed ID: 15203576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.